DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer
Ontology highlight
ABSTRACT: DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer
PROVIDER: PRJNA966201 | ENA |
REPOSITORIES: ENA
ACCESS DATA